Cronos Group — Third Quarter 2026 Earnings Summary
Cronos Group reported record net revenue of $63.5 million for the third quarter of 2026, representing a 73% increase on an organic, constant-currency basis compared to the prior year. The company achieved record Adjusted EBITDA of $17.1 million and maintained the number one market share for its Spinach brand in Canadian vapes and edibles while securing its eleventh consecutive quarter of record revenue in Israel. International operations outside of Israel also delivered record results, driven by strong demand in Germany, and the company completed the acquisition of CanAdelaar B.V. in October 2026 to expand its European presence. Additionally, Cronos repurchased 3.2 million shares for $9.4 million during the quarter and maintained a robust balance sheet with over $840 million in cash and short-term investments.
- Company
- CRONOS GROUP INC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic